Histoplasmosis is a common lung infection caused by microscopic fungal spores that reside in soil. Most people who inhale the spores don't get sick, but for those with weakened immune systems, the infection can become severe. ...
Sep 24, 2018
0
0
Currently, people receiving organ transplants must take drugs to suppress the inflammatory immune response that leads to rejection. Even so, almost all recipients eventually lose their transplant. A new approach, which maintains ...
Jul 9, 2018
0
12
(HealthDay)—Although patients with pre-existing autoimmune disease who receive checkpoint inhibitors (CPIs) are at risk for exacerbation of their disease, immune-related adverse events (irAEs), or both, events can often ...
Jan 4, 2018
0
7
A new study provides insights on the mechanisms that allow an individual's immune system to accept, rather than reject, a donor kidney. The findings, which appear in an upcoming issue of the Journal of the American Society ...
Nov 30, 2017
0
4
(HealthDay)—Response to immunosuppressive therapy (IST) predicts overall survival (OS) in aplastic anemia (AA), according to a study published online Aug. 29 in the American Journal of Hematology.
Sep 7, 2017
0
0
A new review highlights the potential of nicotinamide (Vitamin B3) for preventing melanoma in high-risk individuals.
Aug 9, 2017
0
4
Kidney transplant patients appear to be at a greater risk of developing melanoma than the general population and risk factors include being older, male and white, findings that corroborate results demonstrated in other studies, ...
Jul 26, 2017
0
12
Researchers from Genethon, the AFM-Telethon laboratory, Inserm (UMR) and the Royal Holloway University of London demonstrated the efficacy of an innovative gene therapy in the treatment of Duchenne muscular dystrophy. Indeed, ...
Jul 25, 2017
0
343
The development of new drugs to fight a common fungal pathogen which kills half a million people globally each year is a step closer thanks to a University of Queensland-led study.
Jul 24, 2017
0
1
(HealthDay)—For pediatric and adolescent oncology patients, a single-dose 13-valent pneumococcal conjugate vaccine (PCV13) is safe and immunogenic, according to a study published online July 11 in Cancer.
Jul 19, 2017
0
2
